Elevated mean platelet volume is associated with presence of colon cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 23, 2014, Pages 10501-10504

  Li, Jia Ying ^a   Li, Ying ^a   Jiang, Zheng ^a   Wang, Rui Tao ^a   Wang, Xi Shan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Colon cancer; Diagnostic indicator; Mean platelet volume; Platelet activation

Indexed keywords

ADULT; AGED; BLOOD; CANCER STAGING; CARCINOMA; CASE CONTROL STUDY; COLONIC NEOPLASMS; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; RISK; STATISTICAL MODEL; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME;

ADULT; AGED; CARCINOMA; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; ODDS RATIO; PLATELET ACTIVATION;

EID: 84921813472     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.23.10501     Document Type: Article

References (36)

1. Anthonisen NR, Skeans MA, Wise RA, et al (2005). The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med, 142, 233-9.
2. Berger JS, Eraso LH, Xie D, Sha D, Mohler ER 3rd (2010). Mean platelet volume and prevalence of peripheral artery disease, the national health and nutrition examination survey, 1999-2004. Atherosclerosis, 213, 586-91.
3. Borsig L (2008). The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther, 8, 1247-55.
4. Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A (2001). Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA, 98, 3352-7.
5. Braekkan SK, Mathiesen EB, Njolstad I, et al (2010). Mean platelet volume is a risk factor for venous thromboembolism: the tromso study, tromso, Norway. J Thromb Haemost, 8, 157-62.
6. Christudoss P, Selvakumar R, Pulimood AB, Fleming JJ, Mathew G (2013). Protective role of aspirin, vitamin C, and zinc and their effects on zinc status in the DMH-induced colon carcinoma model. Asian Pac J Cancer Prev, 14, 4627-34.
7. Chu SG, Becker RC, Berger PB, et al (2010). Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost, 8, 148-56.
8. Connolly GC, Khorana AA (2010). Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score. Thromb Res, 125, 1-7.
9. Ferroni P, Basili S, Martini F, et al (2000). Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Investig Med, 48, 21-7.
10. Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD (2010). Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy. Rheumatol Int, 30, 1125-9.
11. Gawaz M, Langer H, May AE (2005). Platelets in inflammation and atherogenesis. J Clin Invest, 115, 3378-84.
12. Grignani G, Falanga A, Pacchiarini L, et al (1988). Human breast and colon carcinomas express cysteine proteinase activities with pro-aggregating and pro-coagulant properties. Int J Cancer, 42, 554-7.
13. Italiano JE, Richardson JL, Patel-Hett S, et al (2008). Angiogenesis is regulated by a novel mechanism: pro-and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood, 111, 1227-33.
14. Karaman K, Bostanci EB, Aksoy E, et al (2011). The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas. Eur J Intern Med, 22, 95-8.
15. Karpatkin S, Pearlstein E, Ambrogio C, Coller BS (1988). Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest, 81, 1012-9.
16. Kisacik B, Tufan A, Kalyoncu U, et al (2008). Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine, 75, 291-4.
17. Konstantopoulos K, Thomas SN (2009). Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng, 11, 177-202.
18. Kozlowski EO, Pavao MS, Borsig L (2011). Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin. J Thromb Haemost, 9, 1807-15.
19. Kurt M, Onal IK, Sayilir AY, et al (2012). The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology, 59, 1580-2.
20. Lee AY (2003). Epidemiology and management of venous thromboembolism in patients with cancer. Thromb Res, 110, 167-72.
21. Li HY, Ge X, Huang GM, et al (2012). GSTP1, ERCC1 and ERCC2 polymorphisms, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in colorectal cancer in Chinese population. Asian Pac J Cancer Prev, 13, 3465-9.
22. Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR (2008). Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology, 134, 29-38.
23. Mueller BM, Reisfeld RA, Edgington TS, Ruf W (1992). Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA, 89, 11832-6.
24. Muscari A, Puddu GM, Cenni A, et al (2009). Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes. Thromb Res, 123, 587-91.
25. Mytnik M, Stasko J (2011). D-dimer, plasminogen activator inhibitor-1, prothrombin fragments and protein C-role in prothrombotic state of colorectal cancer. Neoplasma, 58, 235-8.
26. Neurath MF, Finotto S (2011). IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev, 22, 83-9.
27. Osada J, Rusak M, Kamocki Z, Dabrowska MI, Kedra B (2010). Platelet activation in patients with advanced gastric cancer. Neoplasma, 57, 145-50.
28. Park Y, Schoene N, Harris W (2002). Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets, 13, 301-6.
29. Pauwels RA, Lofdahl CG, Laitinen LA, et al (1999). Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. european respiratory society study on chronic obstructive pulmonary disease. N Engl J Med, 340, 1948-53.
30. Rizzo A, Pallone F, Monteleone G, Fantini MC (2011). Intestinal inflammation and colorectal cancer: a double-edged sword. World J Gastroenterol, 17, 3092-100.
31. Rothwell PM, Wilson M, Elwin CE, et al (2010). Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet, 376, 1741-50.
32. Sierko E, Wojtukiewicz MZ (2004). Platelets and angiogenesis in malignancy. Semin Thromb Hemost, 30, 95-108.
33. Steiropoulos P, Papanas N, Nena E, et al (2012). Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities. Angiology, 64, 535-9.
34. Wei M, Tai G, Gao Y, et al (2004). Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions. J Biol Chem, 279, 29202-10.
35. Weitz J, Koch M, Debus J, et al (2005). Colorectal cancer. Lancet, 365, 153-65.
36. Yuksel O, Helvaci K, Basar O, et al (2009). An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets, 20, 277-81.